Viking Therapeutics Inc.

Viking Therapeutics Inc. annual/quarterly net income history and growth rate from 2014 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

• Viking Therapeutics Inc. net income for the quarter ending March 31, 2026 was -158.3 M, a 246.98% increase year-over-year.
• Viking Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -360.3 M, a 271.14% increase year-over-year.
• Viking Therapeutics Inc. annual net income for 2025 was -359.6 M, a 227.05% increase from 2024.
• Viking Therapeutics Inc. annual net income for 2024 was -110.0 M, a 28.02% increase from 2023.
• Viking Therapeutics Inc. annual net income for 2023 was -85.9 M, a 24.73% increase from 2022.
• Viking Therapeutics Inc. annual net income for 2022 was -68.9 M.